192 related articles for article (PubMed ID: 15369140)
21. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathologic and genotypic study of extranodal nasal-type natural killer/T-cell lymphoma and natural killer precursor lymphoma among Koreans.
Ko YH; Ree HJ; Kim WS; Choi WH; Moon WS; Kim SW
Cancer; 2000 Nov; 89(10):2106-16. PubMed ID: 11066052
[TBL] [Abstract][Full Text] [Related]
23. Genetic regulation on ex vivo differentiated natural killer cells from human umbilical cord blood CD34+ cells.
Pinho MJ; Marques CJ; Carvalho F; Punzel M; Sousa M; Barros A
J Recept Signal Transduct Res; 2012 Oct; 32(5):238-49. PubMed ID: 22762386
[TBL] [Abstract][Full Text] [Related]
24. Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients.
Nagato T; Kobayashi H; Kishibe K; Takahara M; Ogino T; Ishii H; Oikawa K; Aoki N; Sato K; Kimura S; Shimizu N; Tateno M; Harabuchi Y
Clin Cancer Res; 2005 Dec; 11(23):8250-7. PubMed ID: 16322282
[TBL] [Abstract][Full Text] [Related]
25. Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.
Kanavaros P; Boulland ML; Petit B; Arnulf B; Gaulard P
Leuk Lymphoma; 2000 Jul; 38(3-4):317-26. PubMed ID: 10830738
[TBL] [Abstract][Full Text] [Related]
26. Human invariant valpha24+ natural killer T cells activated by alpha-galactosylceramide (KRN7000) have cytotoxic anti-tumour activity through mechanisms distinct from T cells and natural killer cells.
Nicol A; Nieda M; Koezuka Y; Porcelli S; Suzuki K; Tadokoro K; Durrant S; Juji T
Immunology; 2000 Feb; 99(2):229-34. PubMed ID: 10692041
[TBL] [Abstract][Full Text] [Related]
27. Control of NKT cell differentiation by tissue-specific microenvironments.
Yang Y; Ueno A; Bao M; Wang Z; Im JS; Porcelli S; Yoon JW
J Immunol; 2003 Dec; 171(11):5913-20. PubMed ID: 14634102
[TBL] [Abstract][Full Text] [Related]
28. The transcription factor interferon regulatory factor 1 (IRF-1) is important during the maturation of natural killer 1.1+ T cell receptor-alpha/beta+ (NK1+ T) cells, natural killer cells, and intestinal intraepithelial T cells.
Ohteki T; Yoshida H; Matsuyama T; Duncan GS; Mak TW; Ohashi PS
J Exp Med; 1998 Mar; 187(6):967-72. PubMed ID: 9500799
[TBL] [Abstract][Full Text] [Related]
29. Different T-cell receptor gene configurations in T-cell neoplasms and acute lymphoblastic leukemia.
Aisenberg AC; Wilkes BM; Jacobson JO
Cancer Res; 1991 Nov; 51(22):6103-9. PubMed ID: 1834327
[TBL] [Abstract][Full Text] [Related]
30. Differential requirements for the Ets transcription factor Elf-1 in the development of NKT cells and NK cells.
Choi HJ; Geng Y; Cho H; Li S; Giri PK; Felio K; Wang CR
Blood; 2011 Feb; 117(6):1880-7. PubMed ID: 21148815
[TBL] [Abstract][Full Text] [Related]
31. Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro.
Iqbal J; Weisenburger DD; Chowdhury A; Tsai MY; Srivastava G; Greiner TC; Kucuk C; Deffenbacher K; Vose J; Smith L; Au WY; Nakamura S; Seto M; Delabie J; Berger F; Loong F; Ko YH; Sng I; Liu X; Loughran TP; Armitage J; Chan WC;
Leukemia; 2011 Feb; 25(2):348-58. PubMed ID: 21052088
[TBL] [Abstract][Full Text] [Related]
32. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells.
Wingender G; Berg M; Jüngerkes F; Diehl L; Sullivan BA; Kronenberg M; Limmer A; Knolle PA
Eur J Immunol; 2006 Mar; 36(3):570-82. PubMed ID: 16506291
[TBL] [Abstract][Full Text] [Related]
33. T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells.
Townsend MJ; Weinmann AS; Matsuda JL; Salomon R; Farnham PJ; Biron CA; Gapin L; Glimcher LH
Immunity; 2004 Apr; 20(4):477-94. PubMed ID: 15084276
[TBL] [Abstract][Full Text] [Related]
34. Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas.
Boulland ML; Kanavaros P; Wechsler J; Casiraghi O; Gaulard P
J Pathol; 1997 Dec; 183(4):432-9. PubMed ID: 9496260
[TBL] [Abstract][Full Text] [Related]
35. Comparison of Phenotypic and Functional Characteristics Between Canine Non-B, Non-T Natural Killer Lymphocytes and CD3
Lee SH; Shin DJ; Kim Y; Kim CJ; Lee JJ; Yoon MS; Uong TNT; Yu D; Jung JY; Cho D; Jung BG; Kim SK; Suh GH
Front Immunol; 2018; 9():841. PubMed ID: 29755462
[TBL] [Abstract][Full Text] [Related]
36. Cutting edge: the Ets1 transcription factor is required for the development of NK T cells in mice.
Walunas TL; Wang B; Wang CR; Leiden JM
J Immunol; 2000 Mar; 164(6):2857-60. PubMed ID: 10706669
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive cytogenetic study by spectral karyotyping on blastic natural killer cell leukemia/lymphoma.
Jyoko N; Kuroda J; Kimura S; Kobayashi Y; Yoshikawa T
Am J Hematol; 2002 Mar; 69(3):234-5. PubMed ID: 11891818
[No Abstract] [Full Text] [Related]
38. Genetic background influences natural killer cell activation during bacterial peritonitis in mice, and is interleukin 12 and interleukin 18 independent.
Scott MJ; Hoth JJ; Gardner SA; Peyton JC; Cheadle WG
Cytokine; 2004 Nov; 28(3):124-36. PubMed ID: 15473954
[TBL] [Abstract][Full Text] [Related]
39. Characterization of the phenotype and function of CD8(+), alpha / beta(+) NKT cells from tumor-bearing mice that show a natural killer cell activity and lyse multiple tumor targets.
Stremmel C; Exley M; Balk S; Hohenberger W; Kuchroo VK
Eur J Immunol; 2001 Sep; 31(9):2818-28. PubMed ID: 11536181
[TBL] [Abstract][Full Text] [Related]
40. Analysis of Notch1 function by in vitro T cell differentiation of Pax5 mutant lymphoid progenitors.
Höflinger S; Kesavan K; Fuxa M; Hutter C; Heavey B; Radtke F; Busslinger M
J Immunol; 2004 Sep; 173(6):3935-44. PubMed ID: 15356142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
